Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Complete Remissions Observed With Sunitinib in Patients With Metastatic Renal Cell Carcinoma mRCC)

NCT01934452 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01934452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01934452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Complete Remissions Observed With Sunitinib in Patients With Metastatic Renal Cell Carcinoma mRCC)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 21, 2015
Completion date
January 19, 2022
Enrollment
77 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

complete remission in renal cell carcinoma